MLP Care (MPARK)
The analyst analyzes the upward breakout of the 300-410 TRY horizontal formation and the technical target price at the 560 TRY level.
Loading...
Coverage, strength, recency, conviction and momentum.
No analyses found yet.
Newest calls at the top.
The analyst analyzes the upward breakout of the 300-410 TRY horizontal formation and the technical target price at the 560 TRY level.
The speaker scrutinizes the stock with expectations of continued real growth in the healthcare sector in 2026, decreasing indebtedness, and increasing net profit.
The place in model portfolios of the stock, which attracts attention with its growth potential and operational performance in the health sector, is examined.
It is examined as a healthcare sector stock located further down the list that meets the cheapness criteria.
The addition of the company operating in the healthcare sector to the model portfolio and its future projections are interpreted.
The host discusses the company's acquisition of Istanbul Oncology Hospital and the target price updates on the stock by international institutions.
The analyst analyzes the upward breakout of the 300-410 TRY horizontal formation and the technical target price at the 560 TRY level.
The speaker scrutinizes the stock with expectations of continued real growth in the healthcare sector in 2026, decreasing indebtedness, and increasing net profit.
The place in model portfolios of the stock, which attracts attention with its growth potential and operational performance in the health sector, is examined.
It is examined as a healthcare sector stock located further down the list that meets the cheapness criteria.
The addition of the company operating in the healthcare sector to the model portfolio and its future projections are interpreted.
The host discusses the company's acquisition of Istanbul Oncology Hospital and the target price updates on the stock by international institutions.